Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade Journal Article


Authors: Wei, S. C.; Levine, J. H.; Cogdill, A. P.; Zhao, Y.; Anang, N. A. A. S.; Andrews, M. C.; Sharma, P.; Wang, J.; Wargo, J. A.; Pe'er, D.; Allison, J. P.
Article Title: Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
Abstract: Immune-checkpoint blockade is able to achieve durable responses in a subset of patients; however, we lack a satisfying comprehension of the underlying mechanisms of anti-CTLA-4- and anti-PD-1-induced tumor rejection. To address these issues, we utilized mass cytometry to comprehensively profile the effects of checkpoint blockade on tumor immune infiltrates in human melanoma and murine tumor models. These analyses reveal a spectrum of tumor-infiltrating T cell populations that are highly similar between tumor models and indicate that checkpoint blockade targets only specific subsets of tumor-infiltrating T cell populations. Anti-PD-1 predominantly induces the expansion of specific tumor-infiltrating exhausted-like CD8 T cell subsets. In contrast, anti-CTLA-4 induces the expansion of an ICOS+ Th1-like CD4 effector population in addition to engaging specific subsets of exhausted-like CD8 T cells. Thus, our findings indicate that anti-CTLA-4 and anti-PD-1 checkpoint-blockade-induced immune responses are driven by distinct cellular mechanisms. © 2017 Elsevier Inc.
Keywords: melanoma; ctla-4; tumor; pd-1; costimulation; t cell; checkpoint blockade; host immune response; mass cytometry; tumor-infiltrating lymphocyte
Journal Title: Cell
Volume: 170
Issue: 6
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2017-09-07
Start Page: 1120
End Page: 1133.e17
Language: English
DOI: 10.1016/j.cell.2017.07.024
PROVIDER: scopus
PMCID: PMC5591072
PUBMED: 28803728
DOI/URL:
Notes: Article -- Export Date: 2 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jacob H Levine
    7 Levine
  2. Dana Pe'er
    108 Pe'er